FDA Approves Expanded Labeling of MDT InterStim

FDA has expanded MRI labeling of its InterStim™ II and InterStim™ Micro sacral neuromodulation (SNM) systems that use SureScan™ MRI leads, reports Medtronic.

This is a content summary only. Visit us at https://infomeddnews.com

This is not a CAPTIS article. Originally, it was published here.